Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Compare tax exposure between dividend ETFs and taxable funds in 2024 to identify the lower-tax option for your goals.
28,172 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
History says you'll regret not buying Amazon stock if you wait for perfect timing. This guide breaks down the lessons...
A Seoul hotel launches a robot napkin-folding pilot, part of a broader push into physical AI that blends staff skills...
OpenAI has filed confidential IPO paperwork with the SEC, signaling a public listing could be on the horizon. The mov...
Roblox shares slid 9% today, pushing the year-to-date drop to roughly 42%. The move came amid broad risk-off trading ...
Robinhood's Vlad Tenev signals a pivot for crypto toward tokenized real-world assets, stepping away from meme coins a...
In a swift policy shift, the administration moves to impose 25% tariffs on Brazil after the Supreme Court blocked an ...
Grail stock faced another sharp move as trial news weighed on sentiment. This guide unpacks why the slump happened, w...
XRP is testing a key technical juncture, with a weekly close above the 200 EMA and $1.55 potentially weakenting the b...
Howard Hanna Holdings has reached a master settlement to resolve a wave of homebuyer commission lawsuits, signaling a...
Senator Elizabeth Warren escalates her opposition to the OCCs handling of crypto trust charters, arguing the agency h...
FIFA defends ticket prices as market-driven, but economists argue the pricing system is designed to maximize revenue ...